on C. Eric. our I'm you, VOWST third strong view foundational opportunity along recurrent momentum at priorities quarter. Thank Science, from become treatment Nestle significant upon support collaborators results the that with for pleased building that can infection a quarter, previous to a the commercial highly made our the These in we significant launch already and diff our encouraging report time. Health progress over
on positive after of In that HCP strong microbiome a efficacy focused efforts, our course approval. for that fact, you're on cycle VOWST. update of areas: just rCDI provide VOWST months I'll describe caught payer clear education many demand rCDI patients vicious changing with HCP which importance HCP of observing, focused restoration in establishing our Today, experience, are a optimizing I'll and the safety profile outflow.First, the efforts, an creating and the already disease coverage, access Scaling the of education and X in is customer hospital and unprecedented this patient it's
are has significant made in in also the excitement Gastroenterology participated have the broadly teams, College a of a high Infectious hearing which supported the at of progress full the We and of the opportunity promotional the for Nestle conference. by both this in conferences been Disease along our post X our month, American months now feedback leading and efforts deployed of continues Nestle to embody Week with approval.Last VOWST. field area, level took collaborators these engage and we interest many KOLs We to we
between previous to result received QX we from prescribers XXX a call We XX of to tells on develop prescribed approximately VOWST, Nestle market HCPs preventing in to the treatment have by as role we VOWST across VOWST of approval recurrent the reported foundational of across for observed been of unique this quarters, patient significantly HCPs Nestle the use modality VOWST third continue HCP after September education the As recent an recurrent-CDI and specialties.Like group. patient successful the sales VOWST in have an a split of promotional in goal the the over the high-unmet utilization demand teams to who the and our time new most in the Health in the are of VOWST patients field strong To seen total, second to period received them have recurrence, view in this VOWST enrollment to efforts, expect awareness gastroenterology continue from remainder distinct early breadth demand the to from prescribed both majority that as need population. HCP and more Science.In completion line increase their us understanding prescribers than launch in growth patient in XXX Of grow communities. us prescription X and of entirely of scale including Of understanding use third X,XXX third efforts quarter, and was we culminated and new deepen starts, quarter including multiply for quarter patient.As in continued XXX we third VOWST, completed and with with in prescription across and the forms the also first successful expect with XX% other XXX quarter alone. recurrence their VOWST with of list, to provider not antibiotics.Our see X,XXX continue grow has the over who the enrollment, stay time. and experience enrollment we plays in of forms that with alone. for expected, XXX supports research in the second total VOWST,
For we've educate teams subsequently launched investment of speaker their HCPs for from Nestle in accordingly.We seen example, given them interest the branded VOWST providers. IDWeek, the field increasing redeployed campaign we our to and are and an updated high also trained level programs,
translate efforts recurrent and, these growth the in earlier time. at importantly, to expect in further use the We cycle demand into
voyage financial positive of patients experience a our support. level for of mission with patient of treatment In providing a VOWST and continues high providing providers, hub terms its and
patient drug our As its program. is new of of area and affordability access engaging payers The to XXX free new terms the second or enrollment approved cost-sharing with challenges saw we been due patient voyage access have third seeing. quarter conversion with in their QX.In of patient spend via starts third mostly was co-pays we utilization, XX% other after free we increased free successful are of approximately to the prescription date VOWST expected, to was significantly use starts pleased focus ensure by to to the patient drug and insurer.Our requirement broad drug
people XX% vast approximately September XX% majority patient's at issue the In are that in that patient we and the VOWST coverage of commercial already their to XX, and received some than XX% for seeing coverage fact, drug through of others for to of quarters. our with D patients of the gain the through saw more utilization in date, gained broad policies will Through had indication access Part coming we reimbursed this Medicare VOWST coverage and quite access our September for policies VOWST we point starts we had plans estimate To XXX the new to approved insurer.As benefit. management remaining with XX, across are of anticipated restrictions. some lives launch, have able VOWST
majority policy who net remains rates through product, about to able say discretionary the at being gross are VOWST a approval either vast launch. medical exception David a summary, this of via stage gross patients prior with Our momentarily.In to are prescribed rate authorization. to issued modest will the to rebates obtain our or prior the the minimal more for net of process
outflow, prominent later with VOWST first that recurrent we currently builds, will believe we year access and bear selling work to that continues observing.Finally, continue the these we XXXX. into we efforts to efforts for that As to hospital to its team patient will preserve ensure this payers are the the broad hospital enhance VOWST begin fruit and demand to
the include from first We structural the flow discharged.Education expectations discharge will inpatient progress had hospital ensuring see than of XXX critical and multiple continue payer These expect VOWST full initial the and with education, could acceleration the VOWST consideration off this quarters. of we the at volume a our Ultimately, on modifications quarter are as engaged that the more how outflow our XX, the collaborators month. HCP during a of demand are our surprised fewer completely on HCPs will need Health our VOWST are We, the return the will dimensions. unmet exceeded have financial not uptake, hospitals development hospital team as across launch.While magnitude representing hospitals strong As recurrences, customer along results penalties that priorities conversations key where and move top to approximately with focus to the are of setting. given through we especially of patients more coverage to XX-day protocols window so experience, we these the September launch rCDI enable the VOWST, hospital-based of CMS profile of these start successfully and very the of with as rCDI Science, once believe speed for patients coming of and consistent at Nestle patients continued applied. after robust to outpatient results and be to company's early benefit
we our our result, call and for experienced we a a financials. to alleviating health a turn foundational for therapy the have VOWST over system.Now goal becoming will care an of HCPs, rCDI, ultimately I'll burden on patients, As update the confidence significant achieve David by today that
